Microtubule binding to Smads may regulate TGF beta activity
- PMID: 10678166
- DOI: 10.1016/s1097-2765(00)80400-1
Microtubule binding to Smads may regulate TGF beta activity
Abstract
Smad proteins are intracellular signaling effectors of the TGF beta superfamily. We show that endogenous Smad2, 3, and 4 bind microtubules (MTs) in several cell lines. Binding of Smads to MTs does not require TGF beta stimulation. TGF beta triggers dissociation from MTs, phosphorylation, and nuclear translocation of Smad2 and 3, with consequent activation of transcription in CCL64 cells. Destabilization of the MT network by nocodazole, colchicine, or a tubulin mutant disrupts the complex between Smads and MTs and increases TGF beta-induced Smad2 phosphorylation and transcriptional response in CCL64 cells. These data demonstrate that MTs may serve as a cytoplasmic sequestering network for Smads, controlling Smad2 association with and phosphorylation by activated TGF beta receptor I, and suggest a novel mechanism for the MT network to negatively regulate TGF beta function.
Similar articles
-
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.EMBO J. 1997 Sep 1;16(17):5353-62. doi: 10.1093/emboj/16.17.5353. EMBO J. 1997. PMID: 9311995 Free PMC article.
-
NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.Biochem J. 2005 Mar 15;386(Pt 3):461-70. doi: 10.1042/BJ20040738. Biochem J. 2005. PMID: 15496141 Free PMC article.
-
Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.Mol Cell Endocrinol. 1999 Jul 20;153(1-2):79-90. doi: 10.1016/s0303-7207(99)00086-6. Mol Cell Endocrinol. 1999. PMID: 10459856
-
Smad regulation in TGF-beta signal transduction.J Cell Sci. 2001 Dec;114(Pt 24):4359-69. doi: 10.1242/jcs.114.24.4359. J Cell Sci. 2001. PMID: 11792802 Review.
-
The Smads: transcriptional regulation and mouse models.Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):37-48. doi: 10.1016/s1359-6101(99)00027-1. Cytokine Growth Factor Rev. 2000. PMID: 10708951 Review.
Cited by
-
Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.Mol Cell Biol. 2001 Aug;21(15):5132-41. doi: 10.1128/MCB.21.15.5132-5141.2001. Mol Cell Biol. 2001. PMID: 11438668 Free PMC article.
-
Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.Oncogene. 2006 Mar 23;25(13):1871-86. doi: 10.1038/sj.onc.1209211. Oncogene. 2006. PMID: 16288220 Free PMC article.
-
Cytoskeleton Reorganization in EndMT-The Role in Cancer and Fibrotic Diseases.Int J Mol Sci. 2021 Oct 27;22(21):11607. doi: 10.3390/ijms222111607. Int J Mol Sci. 2021. PMID: 34769036 Free PMC article. Review.
-
Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development.Elife. 2025 May 15;13:RP98257. doi: 10.7554/eLife.98257. Elife. 2025. PMID: 40372775 Free PMC article.
-
Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus.Development. 2007 Dec;134(23):4209-18. doi: 10.1242/dev.010645. Epub 2007 Oct 24. Development. 2007. PMID: 17959720 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous